Hot Features
Premium
Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Período:
Tipo de Línea:
| Volume | 59,988 |
|
|||||
| Noticias | - |
| Nombre de la Acción | Símbolo de la Acción | Bolsa de Valores | Tipo de Valor |
|---|---|---|---|
| Quoin Pharmaceuticals Ltd | QNRX | NASDAQ | Certificado de Depósito |
| Variación del Día (ptos.) | Variación del Día (%) | Último Precio | Hora
|
|
|---|---|---|---|---|
| 0.03 | 4.11% | 0.76 | 13:34:49 |
| Precio de Apertura | Precio Mínimo | Precio Máximo | Precio de cierre | Precio Anterior |
|---|---|---|---|---|
| 0.73 | 0.73 | 0.795 | 0.73 |
| Operaciones | Volume Operado de la Acción | Precio Promedio Ponderado | Volume Financiero | Volumen promedio |
|---|---|---|---|---|
| 356 | 59,988 | 0.7502104 | 45,004 | - |
| Último Operado | Tipo de Operación | Cantidad Operada | Precio Operado | Divisa |
|---|---|---|---|---|
| 13:25:29 | 848 | 0.76 | USD |
Información Financiera Quoin Pharmaceuticals Ltd QNRX
| Capitalización de Mercado [m] | Acciones en circulación | Float | Ingresos | Ganancia/Pérdida | Utilidad por Acción (UPA) | Ratio Precio/Utilidad |
|---|---|---|---|---|---|---|
| 0 | 0.00 | - | 0 | -8.69M | - | - |
| Interés de corto | Dividendos Por Acción | Rendimiento del Dividendo | Fecha esperada de dividendos | Transacciones ejecutivas | % de acciones controladas por todos los ejecutivos y 5% propietarios: |
|---|---|---|---|---|---|
| - | - | - | - |
Noticias sobre Quoin Pharmaceuticals Ltd QNRX
| Fecha | Hora | Fuente | Noticia |
|---|---|---|---|
| 02/5/2024 | 15:10 | GlobeNewswire Inc. | Quoin Pharmaceuticals to Announce First Quarter 2024.. |
| 13/3/2024 | 15:05 | GlobeNewswire Inc. | Quoin Pharmaceuticals Provides Corporate Update and.. |
| 13/3/2024 | 06:03 | IH Market News | Mixed Futures Amidst Quiet Economic Schedule; Oil Prices.. |
| 08/3/2024 | 15:06 | Edgar (US Regulatory) | Form 424B3 - Prospectus [Rule 424(b)(3)] |
| 08/3/2024 | 15:04 | Edgar (US Regulatory) | Form 424B3 - Prospectus [Rule 424(b)(3)] |
| 08/3/2024 | 15:01 | Edgar (US Regulatory) | Form 8-K - Current report |
| 07/3/2024 | 15:05 | GlobeNewswire Inc. | Quoin Pharmaceuticals Announces Fourth Quarter and 2023.. |
| 06/3/2024 | 16:07 | Edgar (US Regulatory) | Form 424B4 - Prospectus [Rule 424(b)(4)] |
| 06/3/2024 | 15:01 | Edgar (US Regulatory) | Form 8-K - Current report |
| 05/3/2024 | 07:00 | GlobeNewswire Inc. | Quoin Pharmaceuticals Announces Pricing of $6.5 Million.. |
| 04/3/2024 | 16:27 | Edgar (US Regulatory) | Form 424B3 - Prospectus [Rule 424(b)(3)] |
| 04/3/2024 | 07:00 | GlobeNewswire Inc. | Quoin Pharmaceuticals Announces FDA Clearance to Recruit.. |
Histórico QNRX
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 1 Month | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 3 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 6 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 1 Year | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 3 Years | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 5 Years | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
